Amisulpride Repurposed As Intravenous Anti-Emetic By Acacia
This article was originally published in The Pink Sheet Daily
Executive Summary
Acacia Pharma also recruits J P Morgan Cazenove to evaluate strategic options and market positioning of repurposed low-dose antipsychotic.